Correlation Between Janux Therapeutics and Aerovate Therapeutics

Can any of the company-specific risk be diversified away by investing in both Janux Therapeutics and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Janux Therapeutics and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Janux Therapeutics and Aerovate Therapeutics, you can compare the effects of market volatilities on Janux Therapeutics and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Janux Therapeutics with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Janux Therapeutics and Aerovate Therapeutics.

Diversification Opportunities for Janux Therapeutics and Aerovate Therapeutics

0.45

Correlation Coefficient

Janux Therapeutics  Aerovate Therapeutics

Very weak diversification

The 3 months correlation between Janux and Aerovate is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Janux Therapeutics and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Janux Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Janux Therapeutics are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Janux Therapeutics i.e., Janux Therapeutics and Aerovate Therapeutics go up and down completely randomly.

Pair Corralation between Janux Therapeutics and Aerovate Therapeutics

Given the investment horizon of 90 days Janux Therapeutics is expected to generate 2.3 times more return on investment than Aerovate Therapeutics. However, Janux Therapeutics is 2.3 times more volatile than Aerovate Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Aerovate Therapeutics is currently generating about 0.08 per unit of risk. If you would invest  5,049  in Janux Therapeutics on September 19, 2024 and sell it today you would earn a total of  912.00  from holding Janux Therapeutics or generate 18.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Janux Therapeutics  vs.  Aerovate Therapeutics

Janux Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Janux Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Janux Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Aerovate Therapeutics

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Janux Therapeutics and Aerovate Therapeutics

The main advantage of trading using opposite Janux Therapeutics and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Janux Therapeutics position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.

The idea behind Janux Therapeutics and Aerovate Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.